Single-cell profiling of acral melanoma infiltrating lymphocytes reveals a suppressive tumor microenvironment

Acral lentiginous melanoma (ALM) is the most common melanoma subtype in non-Caucasians. Despite advances in cancer immunotherapy, current immune checkpoint inhibitors remain unsatisfactory for ALM. Hence, we conducted comprehensive immune profiling using single-cell phenotyping with reactivity screening of the T cell receptors of tumor-infiltrating T lymphocytes (TILs) in ALM. Compared with cutaneous melanoma, ALM showed a lower frequency of tumor-reactive CD8 clusters and an enrichment of regulatory T cells with direct tumor recognition ability, suggesting a suppressive immune microenvironment in ALM. Tumor-reactive CD8 TILs showed heterogeneous expression of coinhibitory molecules, including <i>KLRC1</i> (NKG2A), in subpopulations with therapeutic implications. Overall, our study provides a foundation for enhancing the efficacy of immunotherapy in ALM.

Authors

Institutions

Publication Details

Journal
Science Translational Medicine
Published
2024-12-04
DOI
https://doi.org/10.1126/scitranslmed.adk8832
Citations
19
Primary Topic
Immune Cell Function and Interaction
Type
article
Field-Weighted Citation Impact
4.57
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Single-cell profiling of acral melanoma infiltrating lymphocytes reveals a suppressive tumor microenvironment

Tomohide Tsukahara, Yuka Mizue, Kenta Sasaki, Kohei Horimoto et al.
19 citations
Science Translational Medicine
Immune Cell Function and Interaction
4.57
article

Single-cell profiling of acral melanoma infiltrating lymphocytes reveals a suppressive tumor microenvironment

Tomohide Tsukahara, Yuka Mizue, Kenta Sasaki, Kohei Horimoto, Tokimasa Hida, Toshiya Handa, Serina Tokita, Kenji Murata, Hisashi Uhara, Aiko Murai, Takayuki Kanaseki, Junji Kato, Tomoyuki Minowa, Yoshihiko Hirohashi, Terufumi Kubo, Toshihiko Torigoe, Sayuri Sato, Munehide Nakatsugawa
article en
19 citations

Abstract

Acral lentiginous melanoma (ALM) is the most common melanoma subtype in non-Caucasians. Despite advances in cancer immunotherapy, current immune checkpoint inhibitors remain unsatisfactory for ALM. Hence, we conducted comprehensive immune profiling using single-cell phenotyping with reactivity screening of the T cell receptors of tumor-infiltrating T lymphocytes (TILs) in ALM. Compared with cutaneous melanoma, ALM showed a lower frequency of tumor-reactive CD8 clusters and an enrichment of regulatory T cells with direct tumor recognition ability, suggesting a suppressive immune microenvironment in ALM. Tumor-reactive CD8 TILs showed heterogeneous expression of coinhibitory molecules, including <i>KLRC1</i> (NKG2A), in subpopulations with therapeutic implications. Overall, our study provides a foundation for enhancing the efficacy of immunotherapy in ALM.

Science Translational MedicineVol. 16(776)
Sapporo Medical University (JP), Tokyo Medical University Hachioji Medical Center (JP)
Good health and well-being
Openalex Percentile: Top 4%
Immune Cell Function and Interaction
4.57
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.